Literature DB >> 16305603

Migraine and probable migraine--results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification.

M Lantéri-Minet1, D Valade, G Géraud, M H Chautard, C Lucas.   

Abstract

The 2004 International Headache Society (IHS) classification of headache disorders introduced the new category of probable migraine defined by the existence of all but one of typical migraine criteria. FRAMIG 3, the first nationwide population-based survey performed in France using the 2004 IHS classification, assessed the prevalence of probable migraine and compared its features and management with those of strict migraine. Of a representative sample of 10,532 adult subjects interviewed, 1179 subjects (11.2%) were diagnosed as having strict migraine and 1066 (10.1%) as having probable migraine. The criterion most frequently missing was typical headache duration (4-72 h) and most subjects with probable headache had shorter average headache duration. Migraine severity and disability, although lower than those noted in subjects with strict migraine, were significant in subjects with probable migraine and quality of life impairment was identical among the two groups of migraine sufferers. Strict and probable migraine, which have similar prevalence and impact on migraine subjects, deserve similar medical and therapeutic management.

Entities:  

Mesh:

Year:  2005        PMID: 16305603     DOI: 10.1111/j.1468-2982.2005.00977.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  25 in total

1.  Migraine with aura in patients over 50 years of age: the Marseille’s registry.

Authors:  Anne Donnet; Clément Daniel; Loïc Milandre; Julie Berbis; Pascal Auquier
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

2.  Treatment of migraine and tension-type headache in Croatia.

Authors:  Vlasta Vuković; Davor Plavec; Arijana Lovrencić Huzjan; Mislav Budisić; Vida Demarin
Journal:  J Headache Pain       Date:  2010-03-06       Impact factor: 7.277

Review 3.  Neurostimulation methods in the treatment of chronic pain.

Authors:  X Moisset; M Lanteri-Minet; D Fontaine
Journal:  J Neural Transm (Vienna)       Date:  2019-10-21       Impact factor: 3.575

4.  Epidemiology of headaches in Tehran urban area: a population-based cross-sectional study in district 8, year 2010.

Authors:  Saeed Shahbeigi; Seyed-Mohammad Fereshtehnejad; Navid Mohammadi; Mohammad Mahdi Golmakani; Sayeh Tadayyon; Ghazal Jalilzadeh; Hossein Pakdaman
Journal:  Neurol Sci       Date:  2012-09-26       Impact factor: 3.307

Review 5.  Headache in multiple sclerosis.

Authors:  Norman Putzki; Zaza Katsarava
Journal:  Curr Pain Headache Rep       Date:  2010-08

6.  Safety and efficacy of nimodipine combined with flunarizine in patients with angioneurotic headache.

Authors:  Tao Zhang; Yao Xiao; Shengquan Li
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

Review 7.  Prevalence of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andree
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

8.  Impact of a public sensitization campaign on migraine management in France.

Authors:  Anne Donnet; Michel Lantéri-Minet; Gilles Géraud; Evelyne Guegan-Massardier; Geneviève Demarquay; Pierric Giraud; Christian Lucas; Dominique Valade
Journal:  J Headache Pain       Date:  2009-05-30       Impact factor: 7.277

9.  Epidemiological profiles of patients with chronic migraine and chronic tension-type headache.

Authors:  Sara H Schramm; Mark Obermann; Zaza Katsarava; Hans-Christoph Diener; Susanne Moebus; Min-Suk Yoon
Journal:  J Headache Pain       Date:  2013-05-07       Impact factor: 7.277

10.  The contribution of stress to the comorbidity of migraine and major depression: results from a prospective cohort study.

Authors:  Sonja A Swanson; Yiye Zeng; Murray Weeks; Ian Colman
Journal:  BMJ Open       Date:  2013-03-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.